Tag: 3
DSM – Repurchase of Shares (3 – 7 September 2018)

DSM – Repurchase of Shares (3 – 7 September 2018)

HEERLEN, Netherlands, September 11, 2018 /PRNewswire/ -- Royal DSM, a global science-based company active in Nutrition, Health and Sustainable Living, has repurchased 189,309 ...

Lees verder
PeriCoach® Real-World Data Analysis Reveals Statistically and Clinically Significant Reduction in Incontinence Symptoms Within 3 Weeks

PeriCoach® Real-World Data Analysis Reveals Statistically and Clinically Significant Reduction in Incontinence Symptoms Within 3 Weeks

- Independent US-based biostatistician analyses PeriCoach version 3 real-world data. - At the conclusion of the "8 Week Challenge," more than 75% of users have at least 80% ...

Lees verder
Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Park

Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Park

LONDON, August 3, 2018 /PRNewswire/ -- Britannia Pharmaceuticals Ltd has announced publication of the results of the double-blind phase of the TOLEDO study in Lancet ...

Lees verder
FANC krijgt 500.000 handtekeningen voor sluiting Tihange 2 en Doel 3

FANC krijgt 500.000 handtekeningen voor sluiting Tihange 2 en Doel 3

Op vrijdag 13 juli 2018 overhandigen de directeuren van WISE (Nld.), Nucléaire Stop Kernenergie, 11 Maart beweging (Belgie), Initiative Drei Rosen (D'land) een half miljoen ...

Lees verder
Results From Pivotal Phase 3 PROSPER Trial of XTANDI[TM] (enzalutamide) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Published

Results From Pivotal Phase 3 PROSPER Trial of XTANDI[TM] (enzalutamide) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Published

TOKYO, June 29, 2018 /PRNewswire/ -- Results show enzalutamide plus androgen deprivation therapy significantly reduced the risk of developing metastases or death by 71 ...

Lees verder
Norgine and Its Partner Salix Present New Data From PLENVU® (NER1006) Phase 3 Studies at Digestive Disease Week (DDW) 2018

Norgine and Its Partner Salix Present New Data From PLENVU® (NER1006) Phase 3 Studies at Digestive Disease Week (DDW) 2018

AMSTERDAM, June 5, 2018 /PRNewswire/ -- Norgine B.V. today with its partner Salix Pharmaceuticals, Ltd. ("Salix"), announced that they will present new data from phase 3 ...

Lees verder
Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate

Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate

NOVATO, California, TOKYO and LONDON, May 17, 2018 /PRNewswire/ -- Substantial Healing of Rickets Observed in 72% of Patients Treated with Crysvita Compared to 6% of Patients ...

Lees verder
Persbericht: Datacenter services optimalisatiemodel EvoSwitch genomineerd binnen 3 award categorieën Data Cloud Europe 2018

Persbericht: Datacenter services optimalisatiemodel EvoSwitch genomineerd binnen 3 award categorieën Data Cloud Europe 2018

Amsterdam, 4 mei 2018 – Nadat Evoswitch afgelopen jaar de prijs voor ‘Best Energy Solution’ in de wacht sleepte tijdens de Datacloud Europe Awards ...

Lees verder
DSM – Repurchase of Shares (3 – 5 April 2018)

DSM – Repurchase of Shares (3 – 5 April 2018)

HEERLEN, Netherlands, April 6, 2018 /PRNewswire/ -- Royal DSM, a global science-based company active in health, nutrition and materials, has repurchased 87,000 of its own ...

Lees verder
Bruynzeel Keukens CO₂-prestatieladder niveau 3 gecertificeerd

Bruynzeel Keukens CO₂-prestatieladder niveau 3 gecertificeerd

Vanaf 1 april 2018 is Bruynzeel Keukens, onderdeel van de DKG Groep, CO₂-prestatieladder niveau 3 gecertificeerd. De keukenleverancier is de eerste in de sector die dit ...

Lees verder
BizPress.nl